XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Restatement
9 Months Ended
Oct. 31, 2020
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT

NOTE 6 – RESTATEMENT


Our interim financial statements for the three and nine months ended October 31, 2020 as previously filed with the SEC on November 18, 2020, have been restated. The previously filed financial statements did not reflect the proper conversion rate from Series A Preferred Stock to common stock during the appropriate quarterly interim period. The impact of this restatement on the Company’s Balance Sheet, Income Statement, and Cash Flow are reflected in the tables below:


BALANCE SHEETS


(Unaudited)


   Previously filed       Restated 
   October 31,       October 31, 
   2020   Adjustment   2020 
             
ASSETS            
Total Assets  $-        $- 
                
LIABILITIES & STOCKHOLDERS' DEFICIT               
                
Accounts payable  $620        $620 
Note payable related parties   23,306         23,306 
Total liabilities   23,926         23,926 
                
Commitments and Contingencies   -         - 
                
Stockholders' Equity               
Preferred Series A stock, $0.001 par value, 10,000,000 shares authorized, 10,000,000 shares issued and outstanding, October 31, 2020 and January 31,2020   10,000        10,000 
Common stock, $0.001 par value; 300,000,000 shares authorized, 300,000,000 shares issued and outstanding October 31, 2020 and January 31, 2020   300,000        300,000 
Additional paid in capital   13,851,548    5,400,000    19,251,548 
Retained earnings (deficit)   (14,185,474)   (5,400,000)   (19,585,474)
Total Stockholders' (Deficit)   (23,926)   -    (23,926)
Total Liabilities and Stockholders' (Equity)  $-   $-   $- 

STATEMENTS OF OPERATIONS


(Unaudited)


   Previously filed       Restated 
   Nine months       Nine months 
   ended       ended 
   October 31,       October 31, 
   2020   Adjustment   2020 
Revenue  $-        $- 
                
Operating Expenses:               
Administrative expenses -related party   621,251    5,400,000    6,021,251 
Total operating expenses   621,251    5,400,000    6,021,251 
(Loss) from operations   (621,251)   (5,400,000)   (6,021,251)
Other expense        -      
Other (expense) net   -    -    - 
Income (loss) before provision for income taxes   (621,251)   (5,400,000)   (6,021,251)
Provision for income taxes   -    -      
Net (Loss)  $(621,251)   (5,400,000)  $(6,021,251)
                
Basic and diluted earnings(loss) per common share  $(0.00)  $(0.02)  $(0.02)
                
Weighted average number of shares outstanding   300,000,000    -    300,000,000 

STATEMENTS OF CASH FLOWS


(Unaudited)


   Previously filed       Restated 
   Nine months       Nine months 
   ended       ended 
   October 31,       October 31, 
   2020   Adjustment   2020 
Cash Flows From Operating Activities:               
Net loss  $(621,251)  $(5,400,000)  $(6,021,251)
Adjustments to reconcile net income to net cash provided by (used for) operating activities               
Stock- based compensation   600,000    5,400,000    6,000,000 
Changes in operating assets and liabilities:               
Accounts payable   620         620 
Net cash provided by (used for) operating activities   (20,631)   -    (20,631)
                
Cash Flows From Investing Activities:               
Net cash provided by (used for) investing activities   -         - 
                
Cash Flows From Financing Activities:               
Proceeds from related party loans   20,631         20,631 
Net cash provided by (used for) financing activities   20,631         20,631 
                
Net Increase (Decrease) In Cash   -         - 
Cash At The Beginning Of The Period   -         - 
Cash At The End Of The Period  $-        $- 
                
Supplemental disclosure of cash flow information:               
Cash paid for interest  $-        $-